Consistent with NAFLD results, MyD88 deletion in myofibroblasts significantly decreased the infiltration of F4/80+ macrophages, Gr1+ neutrophils, and CD11b+ monocytes in NAFLD-related HCC (Fig. 5A-B). This evidence concerns the gene MYD88 and metabolic dysfunction-associated steatotic liver disease.